2014 01 02 ebsin spez guide ls events

Euro BioFairs Compass o February 2014

II Guide to Life Sciences Events

SPECIAL 29_EBSIN1-2_13_SPECIAL_EuroBioFairsCompass_2014_tg.indd 29

05.02.2014 11:39:39 Uhr

ICPM2014-JKDGPharMed2013_Highlights-210x275 31.01.14 13:25 Seite 1

P m m ! ra ion og at pr ic ll bl fu u e sp th hi d nt fin i e ed as s le clo en

Smart development for better drugs 20–21 March 2014 | Berlin | Germany

17th ICPM 2014 International Conference on Pharmaceutical Medicine 30th DGPharMed Annual meeting Thursday, 20 March 2014 Joint Track

The new EU Regulation for clinical trials Symposium Track A:

Symposium Track B:

Global scope regulations in Pharmacovigilance

New collaborative models for the pharmaceutical industry

Global education in pharmaceutical medicine and drug development sciences

Clinical Outcome Assessments: Concepts, instruments and regulatory perspectives

Friday, 21 March 2014 Symposium Track A:

Symposium Track B:

Smart clinical operations and monitoring

The role of health care professionals in the future of drug development

Impact of health care systems on the quality of care

Hot regulatory topics: Focus on audits and inspections

Ongoing issues in drug development: The international experience

Foto © shutterstock.com/AR Pictures

Intellectual Property: Case studies around the world

IFAPP International Federation

DGPharMed

of Associations of Pharmaceutical

Deutsche Gesellschaft für

Physicians and Pharmaceutical Medicine

Pharmazeutische Medizin e.V.

www.icpm2014.com 30_EBSIN1-2_14_DEPharMed.indd 1

06.02.2014 13:27:12 Uhr

Nº 1-2 | Volume 13 | 2014

Euro Biofairs Compass Connecting Global Competence

Intro

Mark your calenders!

A number of events are rapidly approaching the European life sciences horizon.

From partnering to scientific congresses, from trade shows to technology offerings – the spring 2014 conference season presents a huge collection of opportunities for boosting your business. This year’s Euro Biofairs Compass once again provides all the information you need on the upcoming conference highlights that are going to have the biggest impact on the European life sciences sector. Here you’ll find everything you have to know to identify your must-attend events.

The Bio-Europe Spring, held this year from 10-12 March in Turin (Italy) will raise the curtain on a pharmaceutical industry that is expected to begin spending an increasing amount of money on external projects. Some 3,000 delegates will meet in the event’s notoriously small partnering cubes for negotiations on some 10,000 opportunities, kick-starting partnerships involving companies across the life science value chain – from large biotech and pharma companies to financiers and innovative start-ups.

This year’s DIA annual EuroMeeting will focus on facilitating debate on key issues in the life sciences industry, from how to involve and inform patients and citizens in the whole life-cycle of health products, to the opportunities and challenges of bringing personalised medicines to market.

Leading biopharma experts from industry, academic research, regulatory agencies and health ministries will meet from 2527 March in Vienna (Austria) to put patient rights at the center of the discussion under the theme “Different perspectives – one vision: Better healthcare for patients“.

The 2nd Austrian Biomarker Symposium 2014 on Early Diagnostics, held from 31 March-1 April in Vienna, provides a unique overview on biomarkers and technologies for a variety of diseases and diagnostic applications. Biomarkers herald a new age in the field of personalised medicine, and the field of molecular markers, imaging technologies and novel point-ofcare diagnostic technologies is rapidly evolving. The symposium offers a unique

31_EBSIN1-2_14_Compass_intro_bk.indd 31

source of information to those interested in biomarkers, with a focus on early diagnostics and market access.

In 2014, analytica will focus on three topics: food analysis, plastics analysis and genetic/bioanalysis. The trade fair will take place from 1-4 April in the Bavarian capital Munich. More than 1,000 exhibitors from around the world will take the opportunity there to present their products and equipment for labs in research and industry. For the first time ever, the event will also offer a special show on occupational health and safety in the workplace.

The Swiss Biotech Day (8 April, Kongresshaus Zurich), the country’s leading bio­tech conference, brings together more than 300 senior executives from Swiss bio­tech companies and senior scientists from leading academic institutions. Organised jointly by German BIOCOM AG and the Swiss Biotech Association (SBA), the event’s 2014 programme highlights will include the presentation of the Swiss biotech report and keynote lectures by renowned industry leaders and scientists.

And Asia’s largest bio event, BIOtech Japan 2014, will for the first time ever feature a partner country, India, as well as a completely new concurrent show – IVD Japan 2014. Some 600 exhibitors from 20 countries will be at the fair showcasing products and technologies to 15,000 visitors. Made up of an Exhibition, Conference, Partnering and Academic Forum, the event will take place from 14-16 May in the Tokyo Big Sight exhibition centre.

B

Welcome to your success laboratory.

Instrumental Analysis l Laboratory Technology Biotechnology l analytica Conference

Internationally leading in the Analysis, Laboratory and Biotechnology sectors.

One hall to dedicated y! olog Biotechn

• Don’t miss the world’s largest exhibition in this sector.

• Get a comprehensive picture of all market leaders in one place.

• Meet international key players in science and research in five halls.

» Get your ticket now:

www.analytica.de/en/tickets

April 1–4, 2014 Messe München 24th International Trade Fair for Laboratory Technology, Analysis, Biotechnology and analytica Conference

06.02.2014 13:34:16 Uhr

32

Nº 1-2 | Volume 13 | 2014

Euro|Biotech|News

Euro Biofairs Compass

10 –12 March 2014 Oval Lingotto Conference Center Turin/Italy

8 th BIO-Europe Spring

New Year – New Deals The eighth annual BIO-Europe Spring taking place from 10–12 March is expected to draw over 2,000 global dealmakers to Turin to take part in 12,000 one-to-one meetings between companies involved in the life science value chain – from large biotech and pharma firms to financiers and innovative startups. The event also features academic innovators and a presentation track that provides early-stage opportunities, giving life science companies poised to build partnerships early on the chance to stake a claim and maximise return on future discovery.

As the springtime counterpart to BIO­ Europe, BIO-Europe Spring continues the tradition of providing life science compa­ nies with high-calibre partnering opportu­ nities. Featuring EBD Group’s acclaimed partnering system, partneringONE, the event enables delegates to efficiently iden­ tify and forge partnerships with companies across the life science value chain. Besides

being one of the most productive partner­ ing events in the world, this spring’s con­ ference programme features direct ac­ cess to the industry’s thought leaders. It includes luminaries from global biotech companies who will speak on issues such as financing early-stage drug discovery, Big Data, orphan diseases, dealmaking strategies, partnering with provider insti­

Greeting

ships and gain the knowledge you need to compete and succeed in global bio­ tech. Turin and the surrounding Pied­ mont region boast a large number of life science facilities, with four univer­ sities, six incubators, 220 R&D centres, the Bio­industry Park Silvano Fumero, and the bioPmed innovation hub. Start off 2014 with direct access to innovation, and join us in Turin!

Biotechnology in Bella Italia BIO-Europe Spring 2014 in Turin offers a one-of-a-kind oppor­ tunity to collaborate – in the form of bio­ pharma par tnering– to form the relation­

32_EBSIN1-2_14_Compass_BIOEurope_ml.indd 32

Florian Schoenhammer Group Managing Director EBD Group

tutions, and successful commercialisation of gene therapies. The company presenta­ tion tracks provide a forum for start-ups, academic innovators, established bio­ tech companies, and large and midsize pharma to present information on prod­ ucts, partnering opportunities and corpo­ rate strategy. An exhibition in the heart of the conference and outstanding evening events provide even more networking op­ portunities.

Set in the northern Italian Piedmont area, this year’s location Turin is a centre of life sciences and biotechnology, with R&D facilities devoted to oncology, immu­ nology, central nervous system, proteom­ ics, bioengineering and bioinformatics. The venue is the former speed skating rink for the 2006 Turin Winter Olympics, the Oval Lingotto. Sponsor bioPmed is a local life sciences innovation cluster that includes 390 companies and several universities and R&D centers. To get more informa­ tion or to register for the event, just head for www.ebdgroup.com/bes.

B

> Quick facts Highlights Major partnering event for pharma, bio­ tech and investment executives; panel discussions; exhibition; networking re­ ceptions; company presentations Venue & Information Oval Lingotto, Via Nizza 10126 Turin, Italy www.ebdgroup.com/bes

07.02.2014 13:22:39 Uhr

Where the global

biotech industry comes to partner

8TH ANNUAL INTERNATIONAL PARTNERING CONFERENCE

BIO-EurOpE SprIng 2014 ®

BIO-Europe Spring® is the springtime counterpart to BIO-Europe® and continues the tradition of providing life science companies with high caliber partnering opportunities.

The event enables delegates to identify, meet and network with companies across the life science value chain from large biotech and pharma companies to financiers and innovative startups.

Ready to enter into deals?

Numerous pharma and biotech companies as well as venture capital groups and exciting emerging companies have already committed to attend.

Producer

www.ebdgroup.com/bes

Supported by

© 2013–2014 EBD GmbH

MARCH 10–12, 2014 TURIN, ITALY

Use registration code: DE021_BES14_EBN

BES14 103 EBN 210x275.indd 1 1 33_EBSIN1-2_14_EBDindd.indd

05.02.201404.02.14 12:49:3216:27 Uhr

34

Nº 1-2 | Volume 13 | 2014

Euro|Biotech|News

Euro biofairs Compass

26TH ANNUAL | VIENNA 2014

EUROMEETING

Different perspectives - one vision: Better healthcare for patients

25 – 27 March 2014 ACV Vienna Vienna / Austria

26th DIA EuroMeeting

Meet up with the pros The DIA’s Annual EuroMeeting is global in scope and attracts over 3,000 professionals from more than 50 countries. It brings together experts from the biopharmaceutical industry, contract research organisations, academic research centres, regulatory agencies and health ministries, as well as delegates from patient organisations. The theme for this year’s EuroMeeting is “Different perspectives – one vision: Better healthcare for patients.”

At the 26th Annual EuroMeeting in Vienna taking place from 25-27 March 2014, attendees will have access to more than 100 sessions in 16 parallel themes. Additionally, they’ll have the chance to hear from 350+ expert speakers, including representatives from the European Medicines Agency (EMA), the European Commission, the Food and Drug Administration (FDA), and regulatory agencies from around the world. Participants can also find out about the latest

innovations in their field by touring the exhibition hall, which will feature 170 companies, and also view the latest research on display through student and professional posters.

EuroMeeting 2014 Co-chair Angelika Joos, the Head of Regulatory Policy EU & Most of World at Merck Sharp and Dohme in Belgium, looks forward to the event: “Vienna is in the centre of Europe – ideal for building bridges between East and West, North and South. The EuroMeeting 2014 will be

Welcome

sions, and broadly encourage their contribution to all themes. We strongly believe that as the complexity of the issues has dramatically increased, everyone needs to know what is happening in other a­reas or disciplines to better anticipate the potential impact of decisions down the line. The EuroMeeting is the place where this cross-fertilisation takes place every year.

Take part in real interdisciplinarity This meeting’s motif is ‘Different perspectives – one vision: Better healthcare for patients’. We are putting patient rights in the centre of our discus-

34_EBSIN1-2_14_Compass_DIA_tg.indd 34

the meeting point and melting pot for all involved in making available the health products of the future.”

The conference will facilitate debate on key issues in the life sciences industry, from how to involve and inform patients and citizens in the whole life-cycle of health products, to the opportunities and challenges of bringing personalised medicines to market.

Other hot topics for discussion include the proposal for the Clinical Trials Regulation, initiatives on Health Technology Assessment (HTA), the start of implementation of the Directive of Falsified Medicines, and how the Horizon 2020 research programme will contribute to innovation and the availability of medicines and treatments.

“It’s the event of the year, and I recommend that professionals working in the regulatory affairs arena come for the exciting presentations from experts in Europe and worldwide,” concludes Christa Wirthumer­ Hoche, Head of the Austrian Medicines and Medical Devices Agency (AGES) and Euro­ Meeting 2014 Co-chair.

B

> Quick facts Registration and Information See EuroMeeting 2014 website at www.diahome.org/EM2014 Venue Austria Center Vienna (ACV) Bruno-Kreisky-Platz 1 A-1220 Wien

Christa Wirthumer-Hoche (photo) Angelika Joos Co-Chairs, Euromeeting 2014

05.02.2014 11:48:20 Uhr

Vienna 2014 26th Annual I Vienna 2014

MEETING EUROMEETING

es - One Vision: Different Perspectives - One Vision: r Patients.

Better Healthcare for Patients.

An unbiased and neutral setting.

“

An unbiased and neutral setting.

“

“

“

a, Austria I 25-27ACV, March Vienna, 2014 Austria I 25-27 March 2014

ipation of global regulatory agencies • Participation of global regulatory agencies ole of Social Media in Healthcare • The Role of Social Media in Healthcare nt perspective throughout the •programme Patient perspective throughout the programme operability for Healthcare Providers • Interoperability Across the EU for Healthcare Providers Across the EU opic Sessions • Hot Topic Sessions pean Commission’s eHealth Action • European Plan 2012-2020 Commission’s eHealth Action Plan 2012-2020 essions in 16 parallel themes, 300+ • 110+expert sessions speakers in 16 parallel themes, 300+ expert speakers e-conference tutorials • 13 pre-conference tutorials Exhibiting companies • 170+ Exhibiting companies

s ter: /EM2014

Unbenannt-15.indd 1 35_EBSIN1-2_14_DIA.indd 1

For all details and to register: diahome.org/EM2014

16:36:14 Uhr 05.02.2014 17:22:44

36

Nº 1-2 | Volume 13 | 2014

Euro|Biotech|News

Euro Biofairs Compass

March 31 – April 1, 2014 Tech Gate Vienna Vienna/Austria

2nd Biomarker Symposium

Getting an early start The 2nd Austrian Biomarker Symposium 2014 on Early Diagnostics provides a unique overview of biomarkers and technologies for a variety of diseases and diagnostic applications. At the event in Vienna, speakers from academia, clinical departments and industry will cover topics ranging from molecular markers for early diagnostics, prevention programmes, imaging technologies, novel POC diagnostic sensor and system technologies to markets for early diagnostics.

During the two-day symposium, international experts from academia and industry will address not only the discovery and validation of early diagnosis biomarkers but also their use in clinical practice, including novel point-of-care sensor and system technologies. The conference brings together innovative and forward-thinking members of the biotech and medical community, including leading biomark-

er researchers and technology leaders. A pioneer in the use of saliva as a diagnostic medium, keynote speaker David Wong (University of California, L.A.), will be giving a lecture on detecting and monitoring diseases using molecules found in spit samples. A second keynote speech held by Anthony Turner (Linköping University) will focus on printed biosensor devices for mhealth. Its target audience includes those

Greeting

early diagnosis and individualised treatment. A major goal of the 2nd Austrian Bio­ marker Symposium is to encourage the biotech community to apply and advance biomarker technologies. Biomarkers herald a new age in the field of personalised medicine. Join us for excellent research, industry expertise and great networking opportunities.

The promise of biomarkers Age-related diseases and cancer pose new challenges for medicine and health systems, and will require novel molecular bio­ logy methods to enable

36_EBSIN1-2_14_Compass_Biomarker-Symposium_bs.indd 36

Martin Weber Head of Business Unit Molecular Diagnostics AIT Austrian Institute of Technology

interested in biomarkers, as well as anyone who focuses on early diagnostics and market access.

The symposium fosters information exchange among researchers and clinicians in several areas. Speakers from various medical universities will present disease prevention programmes like those aimed at cancer and diabetes. Experiences and current challenges in using biomarkers – particularly for minimally invasive diagnosis – are to be addressed in the module “Molecular Markers for Early Diagnostics”. Participants in the “Imaging Technologies” module will showcase state-of-the-art methodologies and their use in clinical routine and research.

The section “Markets for Early Diagnostics” will present views from the diagnostics industry and the European Commission on biomarker usage and commercialisation, while another section will look at novel POC diagnostic sensor and system technologies.

There will also be plenty of networking opportunities during breaks, meals, at the evening event and at the poster sessions. B

> Quick facts When?

Monday 31 March – Tuesday 1 April, 2014 Where?

Tech Gate Vienna Donau-City Straße 1 1220 Vienna, Austria Phone: +43(0) 50550-4406 www.ait.ac.at

07.02.2014 13:23:20 Uhr

37_EBSIN1-2_14_Biotech-Japan.indd 1

07.02.2014 10:21:53 Uhr

38

Nº 1-2 | Volume 13 | 2014

Euro|Biotech|News

Euro Biofairs Compass

8 April 2014 Kongresshaus Zurich Zurich/Switzerland

Swiss Biotech Day

Industry in the Alps The Swiss Biotech Day offers a unique chance to meet top-ranking representatives from the Central European life sciences sector. As in previous years, the Swiss Bio­ tech Association (SBA) will use this annual opportunity to present its latest magnum opus on biotechnology in Switzerland – the Swiss Biotech Report.

One Nation, One Cluster – nowhere does the truth of this Swiss claim grow more apparent than at the Swiss Biotech™ Day in Zurich. The country’s leading bio­tech conference brings together more than 300 senior executives from Swiss biotech companies and senior scientists from leading academic institutions. Organised jointly by German BIOCOM AG

and the Swiss Biotech Association (SBA), the event’s 2014 programme highlights will include the presentation of the Swiss biotech report and keynote lectures by renowned industry leaders and scientists. The Swiss Biotech Day will also host the SBA’s annual general assembly (by invitation only). This will be the first time that the Swiss biotech scene will be

Greeting

once again feature keynotes that shed light on the latest science and business trends in biotechnology, while SBA members also have the chance to meet up for the association’s Annual General Assembly. Attendees will have a unique possibility to enjoy new information from the programme, to meet with old friends, and to network with new colleagues. Reflecting the growth of the industry as a whole – and the rise of interest in the Swiss BiotechTM Day – the conference is moving to a bigger venue, the Zurich Kongresshaus. We look forward to seeing you there!

Where science meets business We would like to thank our numerous stakeholders and interested members of the growing industry. Now in its 16th year, the Swiss Biotech™ Day has become firmly established as one of the most efficient and productive one-day events within the community. This year’s edition will

38_EBSIN1-2_14_Compass_sba_bk.indd 38

meeting at the Kongresshaus Zurich, a traditional venue just a few steps from Lake Zurich, where participants will be able to listen to company presentations from listed and privately­- held Swiss biotech companies, and also take part in accompanying panel discussions. Christian Gattiker, Chief Strategist at Bank Julius Bär & Co. AG, will be on hand to present a global investor’s point of view on the worldwide biotech industry.

Wiltrud Treffenfeldt, CTO Europe, Middle East & Africa at DOW Europe GmbH, will also be sharing her thoughts on how industrial biotechnology is already serving as a driver of economic growth today.

The Swiss Bio­tech™ Day’s targeted audience includes biotech entrepreneurs, investors, analysts and industry stakeholders who are involved in current business and science trends in the European biotech­nology community.

B

> Quick facts When & Where Tuesday, 8 April 2014 Kongresshaus Zurich Gotthardstrasse 5 8022 Zurich/Switzerland Contact & Registration www.swissbiotechday.ch Highlights 10:00 a.m. SBA General Assembly 11:10 a.m. Swiss Biotech Report 11:50 a.m. Keynote address C. Gattiker

Domenico P. Alexakis CEO, Swiss Biotech Association

07.02.2014 13:24:12 Uhr

SWISS BIOTECH DAY 2014

© Anshar73/Fotolia.com

The leading Swiss Biotech Conference and Annual General Assembly of the Swiss Biotech Association

The Swiss Biotech Day is the leading biotechnology conference in Switzerland. Every year, this event brings together more than 200 senior executives from the life science industry across Europe. Program highlights 2014 will include the presentation of the Swiss biotech report and key note lectures by renowned industry leaders and scientists. This event will also host the annual general 22 assembly of the Swiss Biotech Association.

... ONE BIOTECH CLUSTER

The Swiss Biotech Day offers a unique opportunity to meet top ranking representatives of the Central European life science sector.

APRIL 9, 2014 2013 8 APRIL SIX Swiss Exchange, Kongresshaus Zurich,

sector is internationally visible. The project-specific More information on the conference, the complete agenda participating companies (most of them young and internationally less savvy) find a comprehensive partner ConventionPoint, Zurich and a registration form can be found at: Gotthardstrasse Zurich Leading chemical companies are exploring the op...is an alliance of four leading Biotech regions of which is helping to put them in the5, public window. portunities that have been opened up by modern bio- The participating Life Science Regions are important Switzerland (Bio Alps, BioPolo Ticino, Basel Area technology, especially in the field of “white” or indusand Greater Zurich Area). They have combined efinternal carriers of the dynamics in the Biotech secwww.swissbiotechday.ch trial biotechnology. And they are also applying these forts to streamline interests of the national biotech tor, thus enhancing the common understanding of the “WHITE BIOTECHNOLOGY” WORKING GROUP

Sponsors:

Parenteral Contract Manufacturing Service of Hospira

$9(67,1

39_EBSIN1-2_14_SBA-2014.indd 1

technologies, wherever it makes sense. The SBA takes industry. This and more knowledge is brought into such initiatives seriously and has formed a working Europa Bio, the European Biotech Association, where group specifically dedicated to white biotechnology. the SBA is an active member.

The Swiss Industrial Biocatalysis Consortium is an important partner in this effort. The group includes leading multinational companies that support white Supporting Partner: Media Partner: biotechnology as a pillar of economic growth.

The planned activities are in agreement with OECD strategies.

In partnership with the Swiss Biotechnet (see pages European 14/15) the SBA develops training programmes and useBiotechnology ful support tools for the industry. It is of importance Net work that the industry specifies its training needs so that the academic side can create tailor-made education.

This strategy ensures that the industry gets the right Domenico Alexakis workforce with the right education. The SBA profits is Executive Director from the marketing alliance “Swiss Biotech” (see box) of the Swiss Biotech in a multiplied form. Thanks to Swiss Biotech, the Association.

SWISS BIOTECH...

sector. The SWX Swiss Exchange holds a leading position in terms of lifescience listings and offers companies from that industry – be they located in Switzerland or abroad – access to an internationally recognised financial marketplace. The initiative was co-founded by the SBA which also manages Organised by: of Swiss Biotech. the executive office

@

For further information please visit www.swissbiotechassociation.ch www.swissbiotech.org

07.02.2014 13:27:55 Uhr

40

Nº 1-2 | Volume 13 | 2014

Euro|Biotech|News

Euro Biofairs Compass

14 –16 May 2014 Tokyo Big Sight Tokyo /Japan

BIOtech Japan 2014

Asian business hub The 13th edition of Asia’s largest bio event, BIOtech Japan 2014, will take place from 14–16 May at the Tokyo Big Sight. Made up of an exhibition, conference, partnering and academic forum, it gathers 600 exhibitors from 20 countries, 200 presentations and 15,000 visitors. Now co-held with the new show IVD Japan 2014, BIOtech Japan 2014 is set to become even more comprehensive, advanced and attractive.

keynote session has invited industry leaders to speak who are perfect to celebrate the opening of the event: Hiroto Izumi, Cabinet Secretariat Member and Special Advisor to the Prime Minister of Japan, K. Vijay Raghavan, Secretary to the Government of India, Dept. of Biotechnology, Ministry of Science & Technology and Yoshihiko Hatanaka, Representative Director, President & CEO of Astellas Pharma. Because the event brings together the decisionmakers in Japanese and Indian bio/pharma-related policies and top management of one of the world’s leading pharma companies, this is a prime opportunity to learn about strategy and future perspectives. In addition, special sessions will cover the latest trends and research development on hot topics like regenerative medicine, stem cells, immunity and personalised medicine. New themes this year include computer­-aided drug design using Big Data, venture investment and medical device development. Be part of the big event taking place in Tokyo!

B

One of the new features this year is the event’s “2014 Partner Country” – India. In addition to the India Pavilion organised by the Association of Biotechnology Led Enterprises, two Indian industry leaders will speak at the conference on “Stem Cells and Regenerative Medicine Research and Commercialization in India”. By offering deeper insights into one of the most important emerging markets in Asia, BIOtech Japan

2014 is further enhancing its role as Asia’s hub of bio business. Another new feature is a newly-launched concurrent show – the 1st Personalised Medicine & Diagnostics Expo (IVD Japan 2014). Featuring the booming sector of personalised medicine, it aims to gather cutting-edge fields in diagnostic/testing equipment, reagents, contract services, IT, etc. and generate synergy with BIO­tech Japan 2014. The conference

Greeting

series of government-funded projects and its economic recovery, the Japanese bio­ pharma industry has now acquired fresh impetus. We hope BIO­tech Japan will serve as a bridge between Japan and European companies willing to strengthen their international business. I look forward to seeing many European exhibitors and visitors at BIOtech Japan 2014, which is full of new business opportunities and innovations.

> Quick facts

Hajime Suzuki Director, Group VP, Int’l Sales & Marketing Division Reed Exhibitions Japan Ltd.

Contact & Registration visitor-eng.bio@reedexpo.co.jp http://www.bio-t.jp/en/

A bridge between Japan and Europe With the world’s second largest pharma industry, Japan garners a huge amount of global attention as both a leader in technical innovation and as a business market. Fueled by a

40_EBSIN1-2_14_Compass_biotechJapan_bk.indd 40

KeyNote Addresses Hiroto Izumi, Cabinet Secretariat, Special Advisor to the Prime Minister of Japan K. Vijay Raghavan, Secretary to the Government of India Yoshihiko Hatanaka, President & CEO of Astellas Pharma

06.02.2014 13:37:09 Uhr

41_EBSIN1-2_14_Reed.indd 1

07.02.2014 10:19:28 Uhr

42

Nº 1-2 | Volume 13 | 2014

Euro|Biotech|News

EURO BIOFAIRS COMPASS

01 – 04 April 2014 Messe Munich Munich / Germany

ANALYTICA 2014

Technology at its best From 1–4 April 2014, Munich will once again be the centre of the international laboratorytechnology, analysis and biotechnology industry. When this year’s analytica opens its gates, more than 1,000 exhibitors from around the world will be on hand to present their products and equipment for labs in research and industry. For the first time ever, the trade fair will also include a special show on occupational health and safety in the laboratory.

On the first three days of the fair, the international scientific elite will meet at the analytica conference to exchange information on the current state of the analysis sector, as well as its development prospects.

Among others, the topics up for discussion include: Biological Timekeeping by Circadian Clocks, Bio Metallomics, Bioimaging of Tissues and Proteomics in Biomedical Research Drug Testing, and Metabolism in Samples Beyond Conventional Matrices.

The analytica forums are perfect for anyone interested in tips that pertain to specific applications. The latest applications and marketable products from the laboratory and analysis market will be presented in lectures and panel discussions in the Forum Laboratory & Analytics, while experts in the Biotech Forum will explain how to meet the latest challenges in bioanalysis.

In several series of lectures, the Biotech Forum will also pay special attention to the topic of personalised medicine.

Additional information is available at: www.analytica.de/en. 

Modern analysis techniques and innovative biological methods have become indispensible in most branches of industry – for everything from controlling the quality of drinking water to testing functional materials. In 2014, analytica will focus on three areas: food analysis, plastics analysis and genetic/bioanalysis. These topics will also be reflected in the programme of related events and in the Live Labs, where visitors can expect lectures and product

presentations three times a day. As part of the Live Labs, for the first time ever, the fair will also feature a special show on occupational safety and health and safety in the workplace. It will include experimental presentations in German and English on how to avoid fires and explosions in laboratories. Experts will also break down the measures that ensure the best possible health and safety standards for laboratory workers.

GREETING

manufacturers from around the world will give visitors a compact market overview of all the latest laboratory products and equipment. For the first time ever, there will be a special show on occupational health and safety in the workplace. Thanks to its conference and a practice-oriented supporting programme, analytica features an extensive range of events. I look forward to seeing you in Munich!

> QUICK FACTS

Susanne Grödl Exhibition Director analytica

info@analytica.de www.analytica.de/en

Come and see innovation The excitement is building, and not just here at Messe München International. The entire industry is looking forward to April 1, when analytica opens its gates. Leading

42_EBSIN1-2_14_Compass_Analytica_tg.indd 42

TOPICS? Food analysis Plastics analysis Genetic and bioanalysis HOW DO I GET TO MESSE MUNICH? From the airport: Shuttle bus, S1, S8 From the central train station: U2 line

07.02.2014 13:29:11 Uhr